Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NAPROXEN Cause Therapeutic product effect incomplete? 965 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 965 reports of Therapeutic product effect incomplete have been filed in association with NAPROXEN (Naproxen Sodium). This represents 1.8% of all adverse event reports for NAPROXEN.

965
Reports of Therapeutic product effect incomplete with NAPROXEN
1.8%
of all NAPROXEN reports
397
Deaths
546
Hospitalizations

How Dangerous Is Therapeutic product effect incomplete From NAPROXEN?

Of the 965 reports, 397 (41.1%) resulted in death, 546 (56.6%) required hospitalization, and 353 (36.6%) were considered life-threatening.

Is Therapeutic product effect incomplete Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NAPROXEN. However, 965 reports have been filed with the FAERS database.

What Other Side Effects Does NAPROXEN Cause?

Drug ineffective (12,416) Product use issue (4,865) Off label use (4,434) Drug hypersensitivity (4,160) Pain (4,140) Nausea (4,139) Vomiting (3,889) Fatigue (3,659) Diarrhoea (3,498) Dizziness (3,460)

What Other Drugs Cause Therapeutic product effect incomplete?

ALBUTEROL (8,496) ADALIMUMAB (6,986) PREDNISONE (6,709) METHOTREXATE (6,037) TOFACITINIB (4,914) SECUKINUMAB (4,661) BUDESONIDE\FORMOTEROL (4,392) TIOTROPIUM (4,327) MEPOLIZUMAB (4,106) ETANERCEPT (3,961)

Which NAPROXEN Alternatives Have Lower Therapeutic product effect incomplete Risk?

NAPROXEN vs NAPROXEN\NAPROXEN NAPROXEN vs NAPROXEN\PSEUDOEPHEDRINE NAPROXEN vs NAPROXEN\SUMATRIPTAN NAPROXEN vs NARATRIPTAN NAPROXEN vs NASONEX

Related Pages

NAPROXEN Full Profile All Therapeutic product effect incomplete Reports All Drugs Causing Therapeutic product effect incomplete NAPROXEN Demographics